GSA Capital Partners LLP cut its net short in Oncopeptides AB to 0.96%

GSA Capital Partners LLP reported a net short position of 0.96% in Oncopeptides AB, with position date October 16, 2026. Finansinspektionen published the notification on October 19, 2026.

The previous position of this holder was 1.14% on October 13, 2026, so the position changed by −0.18 pp and passed 1.00%. In total, 2 holders have an open net short position of 0.5% or more in Oncopeptides AB, together 1.52%.